1 completed, 1 recruiting, 1 terminated. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Recruiting 1, Terminated 1 |
| Phase 1 | 1 | Terminated 1 |
Follow laninamivir: new trials by email Literature Review of laninamivir trials Research Report on laninamivir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza Oseltamivir, Favipiravir, Zanamivir - Influenza, Influenza, Human | Phase 2 | Recruiting | University of Oxford | 3000 | 2023-02-22 | 2026-04-14 |
| Safety & Pharmacokinetics Study of Inhaled Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Children With Influenza 20 mg laninamivir octanoate, Placebo, 40 mg laninamivir octanoate - Influenza | Phase 1 / Phase 2 | Terminated | Biota Scientific Management Pty Ltd | 15 | 2013-11-01 | 2025-01-13 |
| Efficacy and Safety Study of Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Adults With Influenza 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate, Placebo - Influenza | Phase 2 | Completed | Biota Scientific Management Pty Ltd | 639 | 2013-05-01 | 2018-05-31 |
Influenza, Human (3)
Biota Scientific Management Pty Ltd (2) · University of Oxford (1)
United States (2) · Australia (1) · Belgium (1) · Brazil (1) · Bulgaria (1) · Canada (1) · Colombia (1) · Estonia (1) · France (1) · Germany (1) · Hungary (1) · Laos (1) · Latvia (1) · Mexico (1) · Nepal (1)
John Lambert, PhD (1) · Jolanta Airey, Dr (1)